Modal DNA-Values in Prostate Cancer Patients with Deferred Therapy or Endocrine Therapy
- 1 January 1991
- journal article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 30 (2) , 209-210
- https://doi.org/10.3109/02841869109092352
Abstract
Modal DNA-values were assessed with Pow cytometry ir. 269 patients with newly detected untreated prostate cancer. One hundred and seventy-two patients with low-grade, low-stage, non-metastasized cancers were followed without treatment and in this group initial tumor ploidy had no prognostic value. Ninety-seven patients with clinically more advanced prostat: cancers were subjected to endocrine therapy and in this group ploidy was prognostic regarding cancer-related sunival.Keywords
This publication has 5 references indexed in Scilit:
- Flow Cytometric Determination of Ploidy in Prostatic Adenocarcinoma: A Comparison with Seminal Vesicle Involvement and Histopáthglogicál Grading as a Predictor of Clinical RecurrenceJournal of Urology, 1988
- Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasmsWorld Journal of Urology, 1987
- DNA pattern and cytological findings in fine‐needle aspirates of untreated prostatic tumors. A flow‐cytofluorometric studyThe Prostate, 1981
- Correlation between Ploidy and Prognosis in Prostatic CarcinomaJournal of Urology, 1973
- Cytologic Malignancy Grading of Prostatic Carcinoma by Transrectal Aspiration Biopsy:A Five-year Follow-up Study of 469 Hormone-treated PatientsScandinavian Journal of Urology and Nephrology, 1971